Boston Scientific’s drug-coated balloon meets one-year endpoint
Coronary stenting is a standard procedure for treating patients with coronary artery disease, but the stented section of the artery can become occluded due to plaque or scar tissue. Image credit: Shutterstock/Crevis. Boston Scientific’s clinical trial investigating its Agent drug-coated balloon has met its primary endpoint in a trial evaluating its safety and effectiveness as […]
Positive six-month follow-up results Recor’s renal denervation system
The pooled analysis was from three studies in the RADIANCE programme covering 506 patients. Image credit: Shutterstock/New Africa. Recor Medical has followed up its US Food and Drug Administration (FDA) approval of its Paradise ultrasound renal denervation system earlier this year with positive results from a six-month follow-up of its RADIANCE trials. The pooled analysis, […]
Pramana, Techcyte partner for digital diagnostics technology
Pramana and Techcyte will offer volumetric scanning and digital diagnostics technology for cytology and haematology applications. Credit: OsloMetX from Pixabay. Pramana has collaborated with Techcyte to provide volumetric scanning and digital diagnostics technology for microbiology, cytology and haematology applications. Under the partnership, Pramana’s Spectral M and Spectral HT intelligent whole slide imaging systems will be […]
Boston Scientific reports net sales increase in Q3 2023
The company expects an approximate 11% increase in net sales for the full year 2023 compared to the earlier year. Credit: Boston Scientific Corporation. Boston Scientific has reported net sales of $3.52bn during the third quarter (Q3) of 2023 compared to $3.17bn in the year-ago period. This growth is evident across various measures, with an […]
Philips launch AI imaging and reporting tools to support prostate cancer care
Data from Prostate Cancer UK shows that 1 in 8 men will be diagnosed with prostate cancer in their lifetime, with over 12,000 men dying from it a year in the UK alone. Credit: Gorodenkoff/Shutterstock Spain based imaging data software provider, Quilbim has come together with Phillips to provide an artificial intelligence (AI) based imaging […]
Personalis start early access program for cancer detection blood test
NeXT Personal Dx has a specificity exceeding 99.9% and can detect down to 1×10-⁶ tumour fraction. Credit: ArtemisDiana / Shutterstock. Personalis has launched the Early Access Program for NeXT Personal Dx, a liquid biopsy laboratory-developed test for detecting molecular residual disease (MRD) and recurrence in cancer. NeXT Personal Dx is a whole genome sequencing test […]
Edwards receives CE Mark for MITRIS RESILIA valve
The valve is produced using bovine pericardial tissue technology to reduce calcium accumulation. Credit: Edwards Lifesciences / Business Wire. Edwards Lifesciences has obtained a CE Mark for the MITRIS RESILIA valve, a tissue valve replacement designed for the mitral position of the heart. The valve is produced using bovine pericardial tissue technology to minimise calcium […]
Paige receives breakthrough designation for cancer software
The AI-based software helps detect breast cancer metastases in lymph node tissue. Credit: Paige AI. Paige has received breakthrough device designation from the US Food and Drug Administration (FDA) for its in vitro diagnostic medical device software, Paige Lymph Node. The new artificial intelligence (AI)-based application is intended for detecting breast cancer metastases in lymph […]
Medical privacy protections cannot overcome users who do not follow best practices
Previous data breaches were able to obtain email and password combinations from other companies, which rendered the user accounts for 23andMe vulnerable to attack individually. Credit: Victor Moussa / Shutterstock. The 23andMe breach of confidential information based on genetic analysis appears to have been caused by users using identical login information across multiple platforms. Previous […]
No more Dr Google: the rise of symptom checking apps
GlobalData forecasts the regulated medical apps market will be worth about $12.2bn by 2030. Image Credit: greenbutterfly / Shutterstock. We have all used the internet as a self-diagnosis tool to find out the severity of our symptoms. As Google is known to give confusing and unsubstantiated information there has been a rise in symptom-checking apps […]